Figure 1From: Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progressionAssociation between CDC20 expression and PDAC patient survival. (a) A human PDAC tissue microarray was stained with anti-CDC20 antibody (100×). (b) Well-differentiated malignant pancreatic duct with positive CDC20 signaling (400×). (c) Poorly differentiated PDAC tissue with positive CDC20 signaling (400×). (d) Benign duct with negative CDC20 signaling 400×. (e) CDC20 expression was not associated with overall survival in PDAC patients. (f) CDC20 expression was associated with recurrence-free survival in PDAC patients. Upper curve, patients with low CDC20 expression; lower curve, patients with high CDC20 expression.Back to article page